123 related articles for article (PubMed ID: 12802180)
1. Differential expression patterns of mGluR1 alpha in monkey nigral dopamine neurons.
Kaneda K; Imanishi M; Nambu A; Shigemoto R; Takada M
Neuroreport; 2003 May; 14(7):947-50. PubMed ID: 12802180
[TBL] [Abstract][Full Text] [Related]
2. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
[TBL] [Abstract][Full Text] [Related]
3. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
Haber SN; Ryoo H; Cox C; Lu W
J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
[TBL] [Abstract][Full Text] [Related]
4. Localisation of glutamate receptors in the substantia nigra pars compacta of the monkey.
Ong WY; He Y; Garey LJ
J Hirnforsch; 1997; 38(3):291-8. PubMed ID: 9350499
[TBL] [Abstract][Full Text] [Related]
5. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
[TBL] [Abstract][Full Text] [Related]
6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR
J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
[TBL] [Abstract][Full Text] [Related]
9. Influence of aging on the calbindin-D-28k immunoreactive positive dopaminergic neurons in the substantia nigra pars compacta of rats.
Liu HM; Gao J; Miao H; Xiao CH; Sun Y; Du X; Yuan HH; Yu HL; Gao DS
Neurosci Lett; 2010 Jan; 468(1):3-6. PubMed ID: 19857553
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Kaneda K; Tachibana Y; Imanishi M; Kita H; Shigemoto R; Nambu A; Takada M
Eur J Neurosci; 2005 Dec; 22(12):3241-54. PubMed ID: 16367790
[TBL] [Abstract][Full Text] [Related]
11. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
Bian GL; Wei LC; Shi M; Wang YQ; Cao R; Chen LW
Brain Res; 2007 May; 1150():55-61. PubMed ID: 17397812
[TBL] [Abstract][Full Text] [Related]
12. Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra.
Petri S; Krampfl K; Dengler R; Bufler J; Weindl A; Arzberger T
J Comp Neurol; 2002 Oct; 452(4):360-6. PubMed ID: 12355418
[TBL] [Abstract][Full Text] [Related]
13. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Belzunegui S; Izal-Azcárate A; López B; Marcilla I; Luquin MR
J Neuropathol Exp Neurol; 2009 Jan; 68(1):26-36. PubMed ID: 19104449
[TBL] [Abstract][Full Text] [Related]
14. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.
Wallace BA; Ashkan K; Heise CE; Foote KD; Torres N; Mitrofanis J; Benabid AL
Brain; 2007 Aug; 130(Pt 8):2129-45. PubMed ID: 17584773
[TBL] [Abstract][Full Text] [Related]
15. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.
Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G
Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates.
Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA
Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evidence for localization of NMDAR1 receptor subunit on dopaminergic neurons of the rat substantia nigra, pars compacta.
Wedzony K; Czepiel K; Fijał K
Pol J Pharmacol; 2001; 53(6):675-9. PubMed ID: 11985345
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of glutamate receptors by the dopaminergic neurons of the primate striatum.
Betarbet R; Greenamyre JT
Exp Neurol; 1999 Oct; 159(2):401-8. PubMed ID: 10506511
[TBL] [Abstract][Full Text] [Related]
20. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
Liang Y; Li S; Zou Q; Su B
Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
